Close Menu

stock offering

Uses of the proceeds include funding clinical trials and obtaining FDA clearance for its sDNA colorectal cancer screening test.

The registration allows Exact Sciences to sell up to $150 million in securities, though it said that it has no immediate plans to do so.

Sequenom will not receive any of the proceeds of the sale of these shares by the selling stockholders, who purchased their shares through a private placement in May.

The money will help Wafergen commercially launch its high-throughput PCR system "imminently," according to a company official; and bolster the company's dwindling cash reserves in the interim.

The firm said that it will use funds from the offering to support commercialization of its SmartChip Real-Time PCR System including scale up of manufacturing capabilities for its instruments and chips.

Genomic Health has filed a replacement shelf registration for up to 10 million shares of its common stock in one or more offering.

The firm will use the proceeds to develop and commercialize its lead drug for depression, fund clinical trials for it coronary vasodilator, and other things.

The firm's full-year revenues were up 26 percent, according to the preliminary results. It also expects to offer all remaining shares of common stock on its existing shelf registration statement.

The placing and an open offer could raise up to £6.9 million which would be used to see the company through to breakeven/profitability.

The firm will use the proceeds from the offering for product development efforts and to further its efforts to obtain US Food and Drug Administration clearance of its stool-based DNA colorectal cancer screening product.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.